SC 13G/AAMENDMENTCCCCCIK 0001662579
C4 Therapeutics, Inc.
5%+ passive stake (SC 13G/A) filed .
Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.
Filing facts
- Accession number
- 0000895421-26-000231
- Filer
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 0001662579
- Form type
- SC 13G/A
- Form description
- 5%+ passive stake
- Filed at
- August 12, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1662579/000089542126000231/0000895421-26-000231-index.htm ↗Filer's full EDGAR submission history
EDGAR · C4 Therapeutics, Inc. (0001662579) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0000895421-26-000231.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.